| AITL | Angio-immunoblastic T-cell lymphoma |
| aKG | a-ketoglutarate |
| allo-HCT | allogeneic hematopoietic cell transplantation |
| ADC | antibody–drug conjugate |
| AP1 | activator protein 1 |
| ASCT | autologous stem-cell transplantation |
| Bcl-6 | B-cell lymphoma 6 |
| BM | bone marrow |
| BV | Brentuximab vedotin |
| BsAb | bispecific antibodies |
| BTK | bruton tyrosine kinase |
| A+CHP | BV plus cyclophosphamide, doxorubicin and prednisone |
| CAR T | chimeric antigen receptor T-cell |
| CARD11 | a scaffold protein that organizes signaling complexes essential for adaptive immunity |
| Cas9 | CRISPR-associated protein 9 |
| CCL17 | CC chemokine ligand 17 |
| CCR4 | C-C chemokine receptor type 4 |
| CeO2 | cerium oxide |
| CHOEP | etoposide +CHOP |
| CHOKA | choline kinase a |
| CHOP | cyclophosphamide + doxorubicin + vincristine + prednisolone chemo regiment |
| CPT1 | carnitine palmitoyltransférase 1 |
| CR | complete response |
| CREBBP | CREB binding lysine acetyltransferase |
| CRISPR | clustered regularly interspaced short palindromic repeats |
| CTNNB1 | Catenin Beta 1 |
| CXCL13 | C-X-C motif chemokine ligand 13 |
| CXCR5 | C-X-C motif chemokine receptor 5 |
| D2HG | D-2-hydroxyglutarate |
| DNMT3 | DNA methyltransferase |
| EP300 | EP300 Lysine Acetyltransferase |
| ETC | electron transport chain |
| EZH2 | Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit |
| Fas | Fas Cell Surface Death Receptor |
| FDA | U.S. Food and Drug Administration |
| FDC | follicular dendritic cells |
| FER | FER tyrosine kinase |
| FYN | FYN proto-oncogene, Src family tyrosine kinase |
| GAPDH | glyceraldehyde 3-phosphate dehydrogenase |
| GC | germinal center |
| GSEA | gene set enrichment analysis |
| GTPase | hydrolase enzymes that bind to the nucleotide guanosine triphosphate (GTP) and hydrolyze it to guanosine diphosphate (GDP). |
| HDACi | histone deacetylase inhibitor |
| HETP | 5-Hydroxyethyl 5,3′ thiophenyl pyridine |
| IC | immune checkpoint |
| IC50 | median inhibitory concentration |
| ICOS | Inducible T-cell costimulator |
| IDH2 | isocitrate dehydrogenase-2 |
| IKK | IκB kinase |
| IL-6 | interleukin 6 |
| ITK | IL2 Inducible T-Cell Kinase |
| JAK1/2 | janus kinase 1/2 |
| KDM6A | gene Lysine Demethylase 6A |
| KMT2D | lysine Methyltransferase 2D |
| LPC | lysophosphatidylcholine |
| LPCAT1 | lysophosphatidylcholine acyltransferase 1 |
| MAPK | mitogen-activated protein kinase |
| MMAE | microtubule-destroying agent monomethyl auristatin E |
| mAbs | monoclonal antibodies |
| mTOR | mechanistic target of rapamycin |
| NEMO | subunit of the IκB kinase complex that activates NF-κB |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B-cells |
| NFAT | nuclear factor of activated T-cells activator protein 1 |
| NFAT | nuclear factor of activated T-cells |
| NIK | NF-κB-inducing Kinase |
| NK | natural killer cell |
| NP | nanoparticle |
| ORR | objective response rate |
| OS | overall survival |
| OT-II mice | a genetically engineered, transgenic mouse strain widely used in immunology research to study CD4+ helper T-cell responses |
| OXPHOS | oxidative phosphorylation |
| PA | phosphatidic acid |
| PC | phosphatidyl choline |
| PD-1 | programmed cell death protein 1 |
| PDL1 | programmed death-ligand 1 |
| PFS | progression-free survival |
| PI3K | phosphatidylinositol 3-kinase |
| PLCG1 | phospholipase C gamma 1 |
| PLD | phospholipases D |
| PTCL-NOS | peripheral T-cell lymphoma not otherwise specified |
| PTCL | peripheral T-cell lymphoma |
| R/R | relapsed or refractory |
| RHOA | ras homolog family member A |
| ROS | reactive oxygen species |
| STAT | signal transducers and activators of transcription |
| SYK | Associated Tyrosine Kinase |
| TBK1 | TANK-binding kinase 1 |
| TCR | T-cell receptor |
| TET2 | ten-eleven translocation-2 |
| Tfh | follicular helper T-cells |
| TIL | tumor-infiltrating lymphocytes |
| TME | tumor microenvironment |
| TRBC1 | T-cell receptor (TCR) β-chain constant region 1 |
| VAV1 | vav guanine nucleotide exchange factor 1 |
| VEGF | vascular endothelial growth factor |
| WHO | World Health Organization |